Haleos Labs Stock Price Analysis and Quick Research Report. Is Haleos Labs an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Haleos Labs. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Haleos Labs has a PE ratio of 18.0758465473762 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Haleos Labs has ROA of 3.7736% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Haleos Labs has a Current ratio of 1.4082.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Haleos Labs has a ROE of 7.6797%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Haleos Labs has a Debt to Equity ratio of 0.5035 which means that the company has low proportion of debt in its capital.

• Sales growth: Haleos Labs has reported revenue growth of -4.8344% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Haleos Labs for the current financial year is 11.5124386003275%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Haleos Labs is Rs 1.5 and the yield is 0.1257%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Haleos Labs is Rs 66.3814. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Haleos Labs in Ticker for free. Also, one can get the intrinsic value of Haleos Labs by using Valuation Calculators, which are available with a Finology ONE subscription. 

Haleos Labs FAQs

Q1. What is Haleos Labs share price today?
Ans: The current share price of Haleos Labs is Rs 1199.9.

Q2. What is the market capitalisation of Haleos Labs?
Ans: Haleos Labs has a market capitalisation of Rs 362.76420713 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Haleos Labs?
Ans: The PE ratio of Haleos Labs is 18.0758465473762 and the P/B ratio of Haleos Labs is 1.79289526960444, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Haleos Labs share?
Ans: The 52-week high share price of Haleos Labs is Rs 1690, and the 52-week low share price of Haleos Labs is Rs 959.8.

Q5. Does Haleos Labs pay dividends?
Ans: Currently, Haleos Labs pays dividends. Dividend yield of Haleos Labs is around 0.1257%.

Q6. What are the face value and book value of Haleos Labs shares?
Ans: The face value of Haleos Labs shares is Rs 10, while the book value per share of Haleos Labs is around Rs 669.2527. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Haleos Labs?
Ans: Haleos Labs has a total debt of Rs 88.7289 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Haleos Labs?
Ans: The ROE of Haleos Labs is 7.6797% and ROCE of Haleos Labs is 10.9392%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Haleos Labs a good buy for the long term?
Ans: The Haleos Labs long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Haleos Labs undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Haleos Labs appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Haleos Labs’s financials?
Ans: You can review Haleos Labs’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.